Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Rafael Holdings, Inc. | Chief Executive Officer | Class B Common Stock, par value $.01 per share | 521K | $758K | $1.46 | Jun 21, 2024 | Direct |
Cyclo Therapeutics, Inc. | Director | Common Stock | 33.6K | $23.8K | $0.71 | Aug 16, 2024 | Direct |
Cyclo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 15.6K | Jun 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CYTH | Cyclo Therapeutics, Inc. | Aug 16, 2024 | 1 | $0 | 4 | Aug 20, 2024 | Director |
RFL | Rafael Holdings, Inc. | Jun 21, 2024 | 1 | -$19.3K | 4 | Jun 25, 2024 | Chief Executive Officer |
CYTH | Cyclo Therapeutics, Inc. | Jun 3, 2024 | 2 | $0 | 4 | Jun 5, 2024 | Director |
RFL | Rafael Holdings, Inc. | Mar 21, 2024 | 1 | $26.4K | 4 | Mar 25, 2024 | Chief Executive Officer |
CYTH | Cyclo Therapeutics, Inc. | Feb 13, 2024 | 1 | $0 | 4 | Feb 15, 2024 | Director |
RFL | Rafael Holdings, Inc. | Dec 21, 2023 | 1 | $24.8K | 4 | Dec 26, 2023 | Chief Executive Officer |
CYTH | Cyclo Therapeutics, Inc. | Nov 28, 2023 | 1 | $0 | 4 | Nov 30, 2023 | Director |
RFL | Rafael Holdings, Inc. | Oct 25, 2023 | 1 | $60.6K | 4 | Oct 26, 2023 | Chief Executive Officer |
RFL | Rafael Holdings, Inc. | Sep 21, 2023 | 1 | -$30.1K | 4 | Sep 22, 2023 | Chief Executive Officer |
CYTH | Cyclo Therapeutics, Inc. | Aug 18, 2023 | 1 | $0 | 4 | Aug 22, 2023 | Director |
RFL | Rafael Holdings, Inc. | Jun 21, 2023 | 1 | -$32.6K | 4 | Jun 22, 2023 | Chief Executive Officer |
CYTH | Cyclo Therapeutics, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 7, 2023 | Director |
CYTH | Cyclo Therapeutics, Inc. | May 2, 2023 | 0 | $0 | 3 | May 8, 2023 | Director |
RFL | Rafael Holdings, Inc. | Mar 21, 2023 | 1 | -$26.1K | 4 | Mar 23, 2023 | Chief Executive Officer |
RFL | Rafael Holdings, Inc. | Dec 21, 2022 | 1 | -$98.8K | 4 | Dec 23, 2022 | Chief Executive Officer |
RFL | Rafael Holdings, Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 3, 2022 | Chief Executive Officer |